Issue 95, 2014

Practical fluorescence detection of acrolein in human plasma via a two-step tethering approach

Abstract

Acrolein, a cytotoxic α,β-unsaturated aldehyde and disease biomarker, was determined in plasma by means of a novel tethering strategy using Michael addition of the compound to a fluorescent dye, followed by immobilization of the product on microbeads via the aldehyde moiety. Elevation of blood acrolein was detected in mice treated with an anticancer agent cyclophosphamide, which releases acrolein upon activation. This method should be suitable for high-throughput diagnostic and clinical application.

Graphical abstract: Practical fluorescence detection of acrolein in human plasma via a two-step tethering approach

Supplementary files

Article information

Article type
Communication
Submitted
08 Apr 2014
Accepted
09 Jun 2014
First published
19 Jun 2014

Chem. Commun., 2014,50, 14946-14948

Practical fluorescence detection of acrolein in human plasma via a two-step tethering approach

M. Togashi, T. Terai, H. Kojima, K. Hanaoka, K. Igarashi, Y. Hirata, Y. Urano and T. Nagano, Chem. Commun., 2014, 50, 14946 DOI: 10.1039/C4CC02578D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements